Cris Loiren Rodriguez

Array ( [id] => 5342377 [patent_doc_number] => 20090181027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Anti-IL-12/23p40 Antibodies, Epitopes, Formulations, Compositions, Methods and Uses' [patent_app_type] => utility [patent_app_number] => 12/238804 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 41997 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181027.pdf [firstpage_image] =>[orig_patent_app_number] => 12238804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262370 [patent_doc_number] => 20100297093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'MODIFIED T CELL RECEPTORS AND RELATED MATERIALS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/679526 [patent_app_country] => US [patent_app_date] => 2008-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 30706 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297093.pdf [firstpage_image] =>[orig_patent_app_number] => 12679526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264437 [patent_doc_number] => 20090117122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Resistin Antagonists and Their Use' [patent_app_type] => utility [patent_app_number] => 12/233683 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6922 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117122.pdf [firstpage_image] =>[orig_patent_app_number] => 12233683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024272 [patent_doc_number] => 20110052598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'METHOD FOR SCREENING OF THERAPEUTIC AGENT FOR ALLERGIC AIRWAY INFLAMMATION AND/OR AIRWAY HYPERSENSITIVITY USING IL-17RB-POSITIVE NKT CELL' [patent_app_type] => utility [patent_app_number] => 12/745139 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 14233 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052598.pdf [firstpage_image] =>[orig_patent_app_number] => 12745139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575444 [patent_doc_number] => 20090142806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'INTERLEUKIN-17F ANTIBODIES AND OTHER IL-17F SIGNALING ANTAGONISTS AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/196117 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 36072 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142806.pdf [firstpage_image] =>[orig_patent_app_number] => 12196117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650885 [patent_doc_number] => 20110300154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'TREATMENT OF AIRWAY HYPERREACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/674191 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 23788 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300154.pdf [firstpage_image] =>[orig_patent_app_number] => 12674191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4594966 [patent_doc_number] => 07981413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Methods and compositions concerning antibodies that bind CD84-like polypeptides' [patent_app_type] => utility [patent_app_number] => 12/195282 [patent_app_country] => US [patent_app_date] => 2008-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 47387 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981413.pdf [firstpage_image] =>[orig_patent_app_number] => 12195282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834703 [patent_doc_number] => 08450459 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'IL-21 derivatives and variants' [patent_app_type] => utility [patent_app_number] => 12/189849 [patent_app_country] => US [patent_app_date] => 2008-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15750 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12189849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 73240 [patent_doc_number] => 07749500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Antibodies to IL-17 polypeptides and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 12/188054 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 39183 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/749/07749500.pdf [firstpage_image] =>[orig_patent_app_number] => 12188054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4576198 [patent_doc_number] => 07825221 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Antibodies that bind hepatocyte growth factor activator' [patent_app_type] => utility [patent_app_number] => 12/184969 [patent_app_country] => US [patent_app_date] => 2008-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 31653 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/825/07825221.pdf [firstpage_image] =>[orig_patent_app_number] => 12184969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8374917 [patent_doc_number] => 08257707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'IL-18 receptor antigen binding proteins' [patent_app_type] => utility [patent_app_number] => 12/670112 [patent_app_country] => US [patent_app_date] => 2008-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 28443 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12670112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038329 [patent_doc_number] => 20110091378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Methods and Compositions for Treating Fibrosis Related Disorders Using IL-17 Antagonists' [patent_app_type] => utility [patent_app_number] => 12/670179 [patent_app_country] => US [patent_app_date] => 2008-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27652 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091378.pdf [firstpage_image] =>[orig_patent_app_number] => 12670179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5360467 [patent_doc_number] => 20090035261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'IL-17 homologous polypeptides and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 12/214762 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 75503 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035261.pdf [firstpage_image] =>[orig_patent_app_number] => 12214762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134454 [patent_doc_number] => 20110008356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'IL-17 HETEROMERIC RECEPTOR COMPLEX' [patent_app_type] => utility [patent_app_number] => 12/664234 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26194 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008356.pdf [firstpage_image] =>[orig_patent_app_number] => 12664234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340068 [patent_doc_number] => 20100247547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'MODULATION OF THE TH-17 CELL MEDIATED IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 12/602114 [patent_app_country] => US [patent_app_date] => 2008-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13259 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247547.pdf [firstpage_image] =>[orig_patent_app_number] => 12602114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340009 [patent_doc_number] => 20100247538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'IL-18 and Protein Kinase R Inhibition for the Treatment of COPD' [patent_app_type] => utility [patent_app_number] => 12/601778 [patent_app_country] => US [patent_app_date] => 2008-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 28823 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247538.pdf [firstpage_image] =>[orig_patent_app_number] => 12601778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4948950 [patent_doc_number] => 20080305076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'METHOD OF INDUCING MEMORY B CELL DEVELOPMENT AND TERMINAL DIFFERENTIATION' [patent_app_type] => utility [patent_app_number] => 12/126166 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 29323 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305076.pdf [firstpage_image] =>[orig_patent_app_number] => 12126166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6504329 [patent_doc_number] => 20100260770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'IL-33 IN INFLAMMATORY DISEASE' [patent_app_type] => utility [patent_app_number] => 12/600548 [patent_app_country] => US [patent_app_date] => 2008-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 29736 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260770.pdf [firstpage_image] =>[orig_patent_app_number] => 12600548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10083535 [patent_doc_number] => 09120874 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Methods of immunoregulation by albumin neo-structures' [patent_app_type] => utility [patent_app_number] => 12/599484 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 29 [patent_no_of_words] => 17322 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12599484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823042 [patent_doc_number] => 20080227714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Human Tumor Necrosis Factor TR18 and Methods Based Thereon' [patent_app_type] => utility [patent_app_number] => 12/116717 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 111221 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227714.pdf [firstpage_image] =>[orig_patent_app_number] => 12116717 [rel_patent_id] =>[rel_patent_doc_number] =>)